We are live on
!
Find out more
MCMC
Matrix Capital Management Company Portfolio holdings
AUM
$46.3M
1-Year Est. Return
114.38%
This Fund
S&P 500
This Quarter
Est. Return
-4.55%
1 Year Est. Return
+114.38%
3 Year Est. Return
+245.06%
5 Year Est. Return
+259.19%
10 Year Est. Return
+1,887.32%
AUM
$2.09B
AUM Growth
-$11B
(-84%)
Cap. Flow
-$10.9B
Cap. Flow
% of AUM
-519.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
23
New
–
Increased
–
Reduced
4
Closed
16
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.28B |
| 2 |
Qualcomm
QCOM
|
+$1.99B |
| 3 |
TransDigm Group
TDG
|
+$1.4B |
| 4 |
Marvell Technology
MRVL
|
+$1.05B |
| 5 |
ASML
ASML
|
+$948M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 88.42% |
| 2 | Healthcare | 7.27% |
| 3 | Materials | 4.32% |
| 4 | Communication Services | 0% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALTR
1
DELISTED
Altair Engineering Inc
ALTR
| $1.19B | 56.68% |
12,430,000
| – | – |
|
2
GlobalFoundries
GFS
$25.8B
| $665M | 31.74% |
16,514,952
-400,000
| -2% | -$18.6M |
|
3
Perimeter Solutions
PRM
$5.66B
| $90.5M | 4.32% |
6,725,000
-737,500
| -10% | -$7.64M |
|
4
Aura Biosciences
AURA
$725M
| $61.7M | 2.94% |
6,922,870
| – | – |
|
5
Zentalis Pharmaceuticals
ZNTL
$332M
| $51.4M | 2.45% |
13,959,973
| – | – |
|
|
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
| $35.8M | 1.71% |
37,681,515
-1,292,670
| -3% | -$1.47M |
|
7
Adaptive Biotechnologies
ADPT
$3.61B
| $3.33M | 0.16% |
650,000
-10,922,590
| -94% | -$47.6M |
|
8
Amazon
AMZN
$2.44T
| – | – |
-4,703,000
| Closed | -$909M |
|
|
ANSS
9
DELISTED
Ansys
ANSS
| – | – |
-323,778
| Closed | -$104M |
|
|
10
ASML
ASML
$596B
| – | – |
-927,200
| Closed | -$948M |
|
11
BridgeBio Pharma
BBIO
$16.4B
| – | – |
-240,000
| Closed | -$6.08M |
|
12
Geron
GERN
$898M
| – | – |
-571,500
| Closed | -$2.42M |
|
13
Alphabet (Google) Class A
GOOGL
$4.12T
| – | – |
-500,000
| Closed | -$91.1M |
|
|
14
Marvell Technology
MRVL
$147B
| – | – |
-15,055,500
| Closed | -$1.05B |
|
|
15
NVIDIA
NVDA
$4.6T
| – | – |
-26,585,120
| Closed | -$3.28B |
|
16
Okta
OKTA
$23.8B
| – | – |
-575,000
| Closed | -$53.8M |
|
|
17
Qualcomm
QCOM
$164B
| – | – |
-10,000,000
| Closed | -$1.99B |
|
18
Synopsys
SNPS
$71.6B
| – | – |
-717,735
| Closed | -$427M |
|
|
19
TransDigm Group
TDG
$70.7B
| – | – |
-1,094,900
| Closed | -$1.4B |
|
20
Unity
U
$14B
| – | – |
-250,000
| Closed | -$4.07M |
|
21
Veeva Systems
VEEV
$33.8B
| – | – |
-748,821
| Closed | -$137M |
|
22
Workday
WDAY
$41.5B
| – | – |
-1,586,043
| Closed | -$355M |
|
23
Zscaler
ZS
$24.9B
| – | – |
-261,405
| Closed | -$50.2M |
|
Similar funds
CM
RRC
NPCM
FCM
PCM
EGI
IPHI
SM
Matrix Capital Management Company's Q3 2024 Portfolio in Review
As of Q3 2024, Matrix Capital Management Company held 23 positions worth $2.09B, down 84% from $13.1B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Matrix Capital Management Company withdrew a net $10.9B in Q3 2024, closing 16 positions and reducing 4 holdings. Its most notable exit was NVIDIA, an estimated $3.28B position sold in full.
By sector, the portfolio is most concentrated in Technology at 88% of assets, up from 79% a quarter earlier, followed by Healthcare and Materials.
- Matrix Capital Management Company's biggest Q3 2024 reduction was Adaptive Biotechnologies, cutting an estimated $47.6M.
- Matrix Capital Management Company fully exited NVIDIA in Q3 2024, selling an estimated $3.28B.
- Matrix Capital Management Company's ten largest holdings make up 100% of its $2.09B portfolio in Q3 2024.
- Matrix Capital Management Company opened 0 new positions and closed 16 in Q3 2024.
- Matrix Capital Management Company's portfolio value fell 84% quarter-over-quarter to $2.09B.
Based on Matrix Capital Management Company's 13F filing for Q3 2024, filed 14 Nov 2024.